Experts focus on expanding global radiation medicine capabilities
September 28, 2022 -- Improving radiation medicine capabilities in poorer countries is key to bridging the massive global gap in cancer care, according to experts gathered this week during the International Atomic Energy Agency's 2022 Scientific Forum in Vienna. Read More
Varian adds Australia's Icon Group to HyperArc registry
September 26, 2022 -- Siemens Healthineers radiation therapy unit Varian has added Australia's Icon Group to its five-year HyperArc-based radiation therapy registry initiative for patients with brain tumors. Read More
IBA and SCK CEN pick name for autonomous joint venture
September 22, 2022 -- Proton therapy developer Ion Beam Application (IBA) and Belgian nuclear research center SCK CEN announced that their joint venture to produce actinium-225 radioisotopes will be called Pantera. Read More
Isotopia inks deal to supply Lu-177 to Clovis Oncology
September 21, 2022 -- Isotopia Molecular Imaging signed a two-year supply deal to provide Clovis Oncology with lutetium-177 (Lu-177). Read More
Shine inks Lu-177 supply deal with Radiopharm Theranostics
September 20, 2022 -- Shine Technologies has signed an agreement to supply Radiopharm Theranostics with noncarrier-added lutetium-177 (Lu-177). Read More
NorthStar buys two additional accelerators from IBA
September 20, 2022 -- NorthStar Medical Radioisotope has inked a deal to buy two more Rhodotron TT300 HE electron-beam accelerators and associated beamlines from Ion Beam Applications (IBA). Read More
Sirtex gets nod for resin microsphere use in Brazil for HCC treatment
September 16, 2022 -- Radiation oncology firm Sirtex Medical said that the Brazilian National Agency of Supplementary Health has approved the use of its SIR-Spheres Y-90 resin microspheres for treatment of intermediate and advanced stage hepatocellular carcinoma (HCC). Read More
ASTRO applauds legislation on 'real-time' prior authorizations
September 15, 2022 -- The American Society for Radiation Oncology (ASTRO) is applauding passage of legislation in the U.S. House of Representatives intended to revamp Medicare Advantage prior authorization practices. Read More
Radiopharm, MD Anderson launch new theranostics company
September 14, 2022 -- Radiopharm Theranostics and the University of Texas MD Anderson Cancer Center (MD Anderson) have launched a new company that will develop new therapeutic radiopharmaceuticals for cancer treatment. Read More
RayzeBio makes development progress, nets $160M
September 14, 2022 -- Radiopharmaceutical startup RayzeBio has made progress in the development of its RYZ101 targeted radiopharmaceutical candidate and secured $160 million in new financing. Read More
Special Feature
Representation in radiation oncology remains challenging
Radiation oncology has some of the lowest numbers when it comes to female senior faculty representation, according to research published in JAMA Network Open. Read more
VENDOR CONNECT